Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity

This publication has 42 references indexed in Scilit:

• RETRACTED: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas
  Cancer Cell, 2012
• Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes
  Molecular Oncology, 2012
• The role of EZH2 in tumour progression
  British Journal of Cancer, 2011
• Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage
  Cell Death & Differentiation, 2011
• Aberrations of EZH2 in Cancer
  Clinical Cancer Research, 2011
• EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis
  Blood, 2010
• Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas
  Proceedings of the National Academy of Sciences, 2010
• Roles of the EZH2 histone methyltransferase in cancer epigenetics
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2008
• Polycomb-Group Oncogenes EZH2, BMI1, and RING1 Are Overexpressed in Prostate Cancer With Adverse Pathologic and Clinical Features
  European Urology, 2007
• Poorly Differentiated Breast Carcinoma is Associated with Increased Expression of the Human Polycomb Group EZH2 Gene
  Neoplasia, 2003